---
title: Pharmaceutical Companies Are Reassessing Risk Management
description: Today's pharmaceutical companies leverage a data-driven risk management approach to better identify potential issues and possible project disruptions.
image: https://www.enterey.com/hubfs/Digital%20background%20image%20with%20DNA%20molecules.jpeg
---
[Skip to content](https://www.enterey.com/blog/pharmaceutical-companies-are-reassessing-risk-management#main-content)
[-1.png?width=266&height=69&name=Enterey_Color-Logo-withTag%20(1)-1.png)](https://www.enterey.com/)
- [About](https://www.enterey.com/about)
- [Services](https://www.enterey.com/contact)
Show submenu for Services
- [Quality Practice Area](https://www.enterey.com/quality-practice-area)
- [Project Management](https://www.enterey.com/project-management)
- [Change Management](https://www.enterey.com/change-management)
- [Smartsheet](https://www.enterey.com/smartsheet-consulting)
- [Data Analysis & Visualization](https://www.enterey.com/data-analysis-visualization-consulting-1)
- [New Product Introduction](https://www.enterey.com/new-product-introduction)
- [Resources](https://www.enterey.com/blog)
Show submenu for Resources
- [Case Studies](https://www.enterey.com/case-studies-1)
- [Blogs](https://www.enterey.com/blog)
- [Podcasts](https://www.enterey.com/podcasts)
- [Capabilities Summary](https://www.enterey.com/capabilities)
- Partners
Show submenu for Partners
- [Smartsheet](https://www.enterey.com/smartsheet-consulting)
- [MasterControl](https://www.enterey.com/partners-mastercontrol)
- [Careers](https://www.enterey.com/careers)
- [Contact](https://www.enterey.com/contact)
Open main navigation
Close main navigation
- [About](https://www.enterey.com/about)
- [Services](https://www.enterey.com/contact)
Show submenu for Services
- [Quality Practice Area](https://www.enterey.com/quality-practice-area)
- [Project Management](https://www.enterey.com/project-management)
- [Change Management](https://www.enterey.com/change-management)
- [Smartsheet](https://www.enterey.com/smartsheet-consulting)
- [Data Analysis & Visualization](https://www.enterey.com/data-analysis-visualization-consulting-1)
- [New Product Introduction](https://www.enterey.com/new-product-introduction)
- [Resources](https://www.enterey.com/blog)
Show submenu for Resources
- [Case Studies](https://www.enterey.com/case-studies-1)
- [Blogs](https://www.enterey.com/blog)
- [Podcasts](https://www.enterey.com/podcasts)
- [Capabilities Summary](https://www.enterey.com/capabilities)
- Partners
Show submenu for Partners
- [Smartsheet](https://www.enterey.com/smartsheet-consulting)
- [MasterControl](https://www.enterey.com/partners-mastercontrol)
- [Careers](https://www.enterey.com/careers)
- [Contact](https://www.enterey.com/contact)
-
Aug 4, 2021 12:10:28 PM
# Pharmaceutical Companies Are Reassessing Risk Management
 [Michael Ferletic](https://www.enterey.com/blog/author/michael-ferletic)
Share: [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://www.enterey.com/blog/pharmaceutical-companies-are-reassessing-risk-management) [envelope icon](mailto:?body=https://www.enterey.com/blog/pharmaceutical-companies-are-reassessing-risk-management)
Pharmaceuticals companies in every [life science vertical](https://www.enterey.com/) have always prioritized risk management to protect proprietary information and stay ahead of the technology curve. However, over the last several years, risk management in pharma has undergone a tangible shift within the marketplace. Consistently evolving regulations, coupled with an unexpected and prolonged global pandemic, have meant that pharmaceutical organizations’ risk management processes are under more intense scrutiny than ever before. As a result, regulatory entities across the globe have dismissed restrictive, standardized risk management methodologies to embrace a more data-driven approach that focuses on shorter project milestones for an enhanced assessment of potential issues and disruptions.
Understanding compliant and efficient risk management strategies in the current pharmaceutical landscape can help organizations maintain regulatory compliance as well as attain better project outcomes. MasterControl’s June article, ***The Rise of Risk: How To Meet Pharma Regulators’ Expectations***, gives insight into how pharmaceutical companies are successfully navigating the risk management process in their organizations. [Click here](https://www.mastercontrol.com/gxp-lifeline/the-rise-of-risk-how-to-meet-pharma-regulators-expectations/) to read the full article by James Jardine, Staff Writer at MasterControl.
Contact Enterey’s Life Science Consulting Professionals Today
[Contact Enterey Consulting](https://www.enterey.com/contact) to learn more about using our life science consulting services and [project management solutions](https://www.enterey.com/project-management) to lower risk throughout your organization.
[Compliance](https://www.enterey.com/blog/tag/compliance), [Project Management](https://www.enterey.com/blog/tag/project-management), [Efficiency](https://www.enterey.com/blog/tag/efficiency), [Life Science](https://www.enterey.com/blog/tag/life-science)
## Related posts
[](https://www.enterey.com/blog/power-of-health-data)
[Project Management](https://www.enterey.com/blog/tag/project-management), [Program Management](https://www.enterey.com/blog/tag/program-management), [Efficiency](https://www.enterey.com/blog/tag/efficiency), [Quality-Regulatory](https://www.enterey.com/blog/tag/quality-regulatory), [PPM](https://www.enterey.com/blog/tag/ppm), [Project Portfolio Management](https://www.enterey.com/blog/tag/project-portfolio-management), [Life Science](https://www.enterey.com/blog/tag/life-science), [Healthcare](https://www.enterey.com/blog/tag/healthcare)
## [Unlocking the Power of Health Data: Navigating from Information to Action](https://www.enterey.com/blog/power-of-health-data)
 [Nancy Coughlin](https://www.enterey.com/blog/author/nancy-coughlin)
Apr 18, 2024 3:28:56 PM
We are collecting a lot more health data today than we have in the past, but turning all those data...
[Read more](https://www.enterey.com/blog/power-of-health-data)
[](https://www.enterey.com/blog/why-your-project-managers-are-disengaged-and-how-to-fix-it)
[Project Management](https://www.enterey.com/blog/tag/project-management), [Efficiency](https://www.enterey.com/blog/tag/efficiency), [Project Managers](https://www.enterey.com/blog/tag/project-managers), [Webinar](https://www.enterey.com/blog/tag/webinar), [Disengagement](https://www.enterey.com/blog/tag/disengagement)
## [Why Your Project Managers are Disengaged - And How to Fix it](https://www.enterey.com/blog/why-your-project-managers-are-disengaged-and-how-to-fix-it)
[Gil Cargill](https://www.enterey.com/blog/author/gil-cargill)
Oct 1, 2021 2:03:17 PM
An engaged workforce can drive a company's success. Unfortunately, recent research in a study by...
[Read more](https://www.enterey.com/blog/why-your-project-managers-are-disengaged-and-how-to-fix-it)
[](https://www.enterey.com/blog/how-operational-planning-reduces-risk-in-your-life-science-management)
[Project Management](https://www.enterey.com/blog/tag/project-management), [Program Management](https://www.enterey.com/blog/tag/program-management), [Operational Planning](https://www.enterey.com/blog/tag/operational-planning)
## [How Operational Planning Reduces Risk in Your Life Science Management](https://www.enterey.com/blog/how-operational-planning-reduces-risk-in-your-life-science-management)
 [Ryan Coughlin](https://www.enterey.com/blog/author/ryan-coughlin)
Jul 21, 2020 8:33:58 AM
A cohesive life science operational plan plays an integral role in the success of virtually any...
[Read more](https://www.enterey.com/blog/how-operational-planning-reduces-risk-in-your-life-science-management)
100 Spectrum Center Drive
Suite 470
Irvine CA 92618
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Tel. 949-336-5200
Email. [hello@enterey.com](mailto:hello@enterey.com)
[Privacy Policy](https://www.enterey.com/privacy-policy)
[-1.png?width=266&height=69&name=Enterey_Color-Logo-withTag%20(1)-1.png)](https://www.enterey.com/)
Copyright © 2026, Enterey Life Sciences Consulting
[Follow us on LinkedIn](https://www.linkedin.com/company/enterey-inc/) [Follow us on Facebook](https://www.instagram.com/entereylifesciencesconsulting/) [Check out our Youtube page](https://www.youtube.com/channel/UCdqJao5TLQLkqb10rq9urkw)
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Michael Ferletic",
"url" : "https://www.enterey.com/blog/author/michael-ferletic"
},
"dateModified" : "2021-08-04T19:11:36.480Z",
"datePublished" : "2021-08-04T19:10:28.000Z",
"headline" : "Pharmaceutical Companies Are Reassessing Risk Management",
"image" : [ "https://www.enterey.com/hubfs/Digital%20background%20image%20with%20DNA%20molecules.jpeg" ],
"mainEntityOfPage" : {
"@id" : "https://www.enterey.com/blog/pharmaceutical-companies-are-reassessing-risk-management",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://www.enterey.com/hubfs/Enterey%20Image%20Assets/Enterey%20Logos/Enterey-Full-Logo-Color.png"
},
"name" : "Enterey, Inc."
}
}
```